During this segment, Genevieve Kumapley, PharmD, BCOP, discusses the significance of introducing a self-care plan to patients who are undergoing cancer treatment.
“There is a value in helping the patient understand what their anticipated side effects are, when to expect them, and how to manage them,” says Dr Kumapley, who notes the importance of proper planning in an era in which oral oncolytics have become primary treatment options.
Dr Kumapley remarks that if established at the beginning of treatment, a self-care plan has the potential to improve overall patient adherence. Currently, she notes, nonadherence rates are up to 30% in patients who are treated with oral oncolytics.
Self-care plans can have a significant impact on the patient’s likelihood of experiencing severe symptoms and can help decrease unnecessary healthcare resource utilization, adds Dr Kumapley.
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen